mTOR inhibitors - Globe Thesis

Keyword [mTOR inhibitors] Result: 1 - 20 \| Page: 1 of 2
1.	Effect Of New Mtor Inhibitor Y31on Cell Proliferation In Adpkd Cysts-lining Epithelial Cell And Its Mechanism
2.	The Effect Of MTOR Inhibitors On Urothelial Bladder Cancer
3.	PI3K/Akt/mTOR Inhibitors Effect On The Response Of Endocrine-and Targeted-therapeutic Drugs In Breast Cancer Stem Cells
4.	A Meta-analysis Of The Genetic Factors On Progression And Treatments In Autosomal Dominant Polycystic Kidney Disease
5.	Establishment Of Screening Models For Inhibitors Targeting IKKÎ² And MTOR Protein Kinases As New Anti-tumor Drugs
6.	Study Of Effects And Mechanism Of MTOR Inhibitors Everolimus On Human Prostate Cancer PC-3Cell Lines In Vitro
7.	The Experimental Studies Of Effect And Its Mechanism Of MTOR Inhibitors On Human Gastric Cancer Cell Lines
8.	The Effects Of MTOR Inhibitors Everolimus On Neuroendocrine Tumors
9.	The Effects Of MTOR Inhibitors Evcrolimus On Neuroendocrine Tumors
10.	The Effects Of MTOR Inhibitors On The Proliferation Of The Thyroid Cancer Cell And The Study Of The Mechanism
11.	The Relationship Between The Expression Level Of Rictor And Cell Sensitivity To MTOR Inhibitors And Its Molecular Mechanism
12.	The Research Of The Correlation Between The Effect Of MTOR Inhibitors On Non-small Cell Lung Cancer Cell Lines And LKB1 Gene
13.	Preliminary Study On The Efficacy And Mechanism Of Rapamycin Target Protein (mTOR) Inhibitor TAC In The Treatment Of Cystic Echinococcosis In Mice
14.	Design,Synthesis,and Antitumor Evaluation Of Novel Dual Pan-PI3K/mTOR Inhibitors
15.	Design,synthesis And Anti-tumor Activities Of Heterocycles-fused Pyrimidine PI3K/mTOR Dual Inhibitors
16.	Mechanism Of MTOR Inhibitor Regulating Drug Sensitivity Of Pancreatic Cancer
17.	A Meta-analysisi Of The Efficacy And Safety Of PI3K/AKT/mTOR Inhibitors Combined Wiht Endocrine Therapy On Advanced Breast Cancer
18.	Design,Synthesis And Antitumor Activity Of Thiophene-Triazines As Dual PI3K/mTOR Inhibitors
19.	Development of selective inhibitors of the mammalian target of rapamycin
20.	Primary resistance to ATP-competitive mTOR inhibitors for the treatment of solid tumors
<<First <Prev Next> Last>> Jump to